|
Ket-A-Xyl®
Injectable Solution
Neuroleptoanalgesic association
FORMULA: Xilazine chlorhydrate (equivalent to base) 20 mg,
ketamine chlorhydrate (equivalent to base) 100 mg, atropine sulphate (equivalent
to base) 1 mg, excipients q.s. ad 1 mL.
THERAPEUTIC INDICATIONS: The association ketamine-xilazine
generates neuroleptoanalgesia that permits to effect a safe surgycal handling
(abdominal cavity, muscles, castration, deep cleaning of mucous tissues, teeth
and surgycal cleaning of abscesses). It provides non dissociative anesthesia.
atropine is included (as premedication in surgery) to avoid increase of excesive
secretions, reduce bronchial mucus, avoid laryngeal spasm during endotracheal
intubation and to prevent the bradycardic effects of ketamine.
DOSAGE AND ADMINISTRATION: Only by intramuscular route, at
a rate of 5 mg-10 mg ketamine/kg of body weignt, 1 mg-2 mg xilacine/kg
of body weight and 0.05 mg-0.1 mg atropine/kg body weight; which in practice
is equivalent to 0.5 mL-1 mL/10 Kg. body weight.
COMMERCIAL PRESENTATION: Glass vial of 10 mL, glass vial of
20 mL, glass vial of 30 mL
ENGOREPROD 465-1116 20080905
 Send to a friend
Copyright © 1999-2008 Engormix.com - All Rights Reserved
|
Who we are / Products and Services
